Miller Financial Services’s CytomX Therapeutics CTMX Stock Holding History

Miller Financial Services’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$237K	Buy	87,000 +2,000	+2%	+$6.67K	0.18%	125
2026 Q2	$319K	Buy	85,000 +13,000	+18%	+$49.6K	0.26%	96
2026 Q1	$338K	Buy	72,000 +4,000	+6%	+$20.3K	0.37%	77
2025 Q4	$290K	Buy	68,000 +1,000	+1%	+$3.8K	0.34%	83
2025 Q3	$214K	Buy	67,000 +16,000	+31%	+$36K	0.25%	100
2025 Q2	$116K	Hold	51,000	–	–	0.15%	105
2025 Q1	$32.4K	Buy	51,000 +26,000	+104%	+$20.2K	0.05%	94
2024 Q4	$25.8K	Buy	+25,000	New	+$26.9K	0.02%	127

Other funds holding CTMX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Congress Park Capital Saratoga Springs, New York $381M AUM 20.14% 1-Year Est. Return

Miller Financial Services's CTMX Position: Q3 2026 in Review

Miller Financial Services increased its CytomX Therapeutics (CTMX) stake by 2.4% in Q3 2026, buying an estimated $6.67K and bringing the position to 87,000 shares worth $237K. The position accounts for 0.18% of the portfolio, ranked #125.

Miller Financial Services first reported a position in CTMX in Q4 2024 and has held it in 8 quarters since. The position peaked at $338K in Q1 2026. 28 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

Miller Financial Services held 87,000 shares of CytomX Therapeutics worth $237K as of Q3 2026.
Miller Financial Services bought 2,000 CytomX Therapeutics shares in Q3 2026, an estimated $6.67K.
CytomX Therapeutics made up 0.18% of Miller Financial Services's portfolio in Q3 2026, its #125 holding.
Miller Financial Services first reported a position in CytomX Therapeutics in Q4 2024 and has held it in 8 quarters since.
Miller Financial Services's CytomX Therapeutics position peaked at $338K in Q1 2026.
28 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.